.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
https://grassfed.us/Fergeson-mother-of-Purter-from-Horn-Lieskov
.
.

.